LILRB1 and neoplasm: HLA-G, which was a nonclassical major histocompatibility complex molecule with immunomodulatory properties [42], could result in immune suppression, driving tumor growth and progression by HLA-G/ILT-2/-4 (HLA-G/ILT) signaling [43].